6533b7d5fe1ef96bd12646b4

RESEARCH PRODUCT

Umbilical Cord Mesenchymal Stromal Cells for Cartilage Regeneration Applications

E. RussoM. CaprndaP. KruzliakP. G. ConaldiC. V. BorlonganG. La Rocca

subject

Settore BIO/17 - IstologiaReview ArticleCell Biologymesenchymal stromal cells stem cells cartilage regenerative medicien tissue engineering immune modulationMolecular BiologyInternal medicineRC31-1245

description

Chondropathies are increasing worldwide, but effective treatments are currently lacking. Mesenchymal stromal cell (MSCs) transplantation represents a promising approach to counteract the degenerative and inflammatory environment characterizing those pathologies, such as osteoarthritis (OA) and rheumatoid arthritis (RA). Umbilical cord- (UC-) MSCs gained increasing interest due to their multilineage differentiation potential, immunomodulatory, and anti-inflammatory properties as well as higher proliferation rates, abundant supply along with no risks for the donor compared to adult MSCs. In addition, UC-MSCs are physiologically adapted to survive in an ischemic and nutrient-poor environment as well as to produce an extracellular matrix (ECM) similar to that of the cartilage. All these characteristics make UC-MSCs a pivotal source for a stem cell-based treatment of chondropathies. In this review, the regenerative potential of UC-MSCs for the treatment of cartilage diseases will be discussed focusing on in vitro, in vivo, and clinical studies.

10.1155/2022/2454168https://doaj.org/article/6de5acd1bf5c40e7ab85c2824baeb3dd